Hosted on MSN1mon
CollPlant secures U.S. patent for dermal filler
CollPlant specializes in regenerative and aesthetic medicine, leveraging its proprietary plant-based technology ... AGN), an AbbVie company and a leader in the dermal filler market, underscores ...
Seeking Alpha4d
Collplant plans clinical trials for dermal filler and advances regenerative implants
CEO Yehiel Tal highlighted advancements in CollPlant's proprietary photocurable dermal filler, emphasizing its potential as a game-changer in the $6.3 billion market for aesthetic medicine.